Baseline S1P concentration was lower among patients with Her2-enriched and triple-negative breast cancer as compared to luminal-type cancer (1119.2 and 1167.1 versus 1280.8 pmol/mL, p < 0.05, Figure 1(c)). This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.